Literature DB >> 29151580

Rituximab or irradiation promotes IL-17 secretion and thereby induces resistance to rituximab or irradiation.

Weijie Zhong1, Qingshan Li2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29151580      PMCID： PMC5719141          DOI： 10.1038/cmi.2017.124

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  15 in total

1.  Anti-CD20 therapy induces a memory Th1 response through the IFN-γ/IL-12 axis and prevents protumor regulatory T-cell expansion in mice.

Authors:  C Deligne; A Metidji; W-H Fridman; J-L Teillaud
Journal:  Leukemia       Date:  2014-09-18       Impact factor: 11.528

Review 2.  Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity.

Authors:  Laurie H Sehn; Randy D Gascoyne
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 3.  Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells.

Authors:  Nasr Y A Hemdan
Journal:  Immunol Lett       Date:  2012-11-15       Impact factor: 3.685

4.  Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy.

Authors:  Juan C Gomez-Gelvez; Mohamed E Salama; Sherrie L Perkins; Matthew Leavitt; Kedar V Inamdar
Journal:  Am J Clin Pathol       Date:  2016-04-22       Impact factor: 2.493

5.  Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.

Authors:  Garam Kim; Prem Khanal; Sung-Chul Lim; Hyo Jeong Yun; Sang-Gun Ahn; Sung Hwan Ki; Hong Seok Choi
Journal:  Carcinogenesis       Date:  2012-11-03       Impact factor: 4.944

Review 6.  Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis.

Authors:  Xin Qian; Hankui Chen; Xiaofeng Wu; Ling Hu; Qi Huang; Yang Jin
Journal:  Cytokine       Date:  2016-02-14       Impact factor: 3.861

7.  Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma.

Authors:  Elisa Ferretti; Emma Di Carlo; Emanuela Ognio; Carla Guarnotta; Francesco Bertoni; Anna Corcione; Ignazia Prigione; Giulio Fraternali-Orcioni; Domenico Ribatti; Jean Louis Ravetti; Maurilio Ponzoni; Claudio Tripodo; Vito Pistoia
Journal:  Oncoimmunology       Date:  2015-06-19       Impact factor: 8.110

8.  Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.

Authors:  Mohan Doss; Hartmuth C Kolb; Joseph C Walsh; Vani Mocharla; Hong Fan; Ashok Chaudhary; Zhihong Zhu; R Katherine Alpaugh; Miriam N Lango; Jian Q Yu
Journal:  J Nucl Med       Date:  2013-10-17       Impact factor: 10.057

Review 9.  Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.

Authors:  Hye Won Lee; Han Yong Choi; Kyeung Min Joo; Do-Hyun Nam
Journal:  Int J Mol Sci       Date:  2015-02-25       Impact factor: 5.923

10.  Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's Lymphoma.

Authors:  Ting Lu; Shuang Yu; Yan Liu; Congcong Yin; Jingjing Ye; Zhi Liu; Daoxin Ma; Chunyan Ji
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240
View more
  4 in total

Review 1.  Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity.

Authors:  Kazuhiko Matsuo; Osamu Yoshie; Takashi Nakayama
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

Review 2.  Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.

Authors:  Aleksandra Kusowska; Matylda Kubacz; Marta Krawczyk; Aleksander Slusarczyk; Magdalena Winiarska; Malgorzata Bobrowicz
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

3.  Construction of tandem diabody (IL-6/CD20)-secreting human umbilical cord mesenchymal stem cells and its experimental treatment on diffuse large B cell lymphoma.

Authors:  Jiayi Zhang; Minglu Zhong; Weijie Zhong; Yanfei Lan; Zhaohu Yuan; Yuyou Duan; Yaming Wei
Journal:  Stem Cell Res Ther       Date:  2022-09-14       Impact factor: 8.079

Review 4.  IL-17-Producing Cells in Tumor Immunity: Friends or Foes?

Authors:  Da-Sol Kuen; Byung-Seok Kim; Yeonseok Chung
Journal:  Immune Netw       Date:  2020-02-07       Impact factor: 6.303
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.